Adverse prognosis of GM-CSF expression in human cutaneous melanoma
Our findings highlight a potentially pro-tumorigenic GM-CSF-driven paracrine axis in patients with poor-prognosis melanoma, supporting therapeutic strategies aimed at disrupting this signaling network.
Authors
- Elena García‐Martínez (ORCID: https://orcid.org/0000-0001-8211-4287)
- J.A. Avilés-Izquierdo (ORCID: https://orcid.org/0000-0001-9451-4392)
- Alba Gutiérrez‐Seijo (ORCID: https://orcid.org/0000-0001-6282-3932)
- Verónica Parra‐Blanco
- Celia Barrio‐Alonso (ORCID: https://orcid.org/0000-0002-2789-1363)
- Baltasar López-Navarro (ORCID: https://orcid.org/0000-0002-4811-5419)
- Alicia Nieto‐Valle (ORCID: https://orcid.org/0000-0001-8236-7591)
- Paloma Sánchez‐Mateos (ORCID: https://orcid.org/0000-0001-6589-4445)
- Rafael Samaniego (ORCID: https://orcid.org/0000-0002-3081-7332)
Institutions
- Hospital General Universitario Gregorio Marañón (ES)
- Inmunal (Spain) (ES)
Publication Details
- Journal
- Neoplasia
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1016/j.neo.2025.101240
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05